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Abstract
Background: Edible Bird’s nest (EBN) is an antioxidant-rich supplement that is popular in many parts of Asia. Its
antioxidant and anti-inflammatory properties have been reported using in vitro system. This paper aimed to
determine the antioxidant and anti-inflammatory effects of EBN in in high fat diet induced rats model.
Methods: We evaluate if those properties can be translated in rats. High fat diet (HFD) was fed to rats for 12 weeks
to determine its effects on oxidative stress and inflammation, and compared with HFD + Simvastatin and HFD + EBN
(2.5 or 20 %). Weights were measured weekly, while serum and hepatic markers of oxidative stress (total antioxidant
status and TBARS) and inflammation (interleukin 6 [IL-6], C-reactive protein [CRP] and tumor necrosis factor alpha
[TNF-α]) were determined at the end of the intervention. In addition, transcriptional changes in hepatic antioxidant
(superoxide dismutase, glutathione reductase, glutathione peroxidase) and inflammation (C-reactive protein, chemokine
[C-C] motif 2, nuclear factor kappa beta 1 and tumor necrosis factor alpha) genes were evaluated.
Results: The results showed increases in oxidative stress (raised TBARS and lowered total antioxidant status) and
inflammatory markers (raised CRP, IL-6 and TNF-α) in HFD induced rats with corresponding attenuation of antioxidant
gene expression and potentiation of inflammatory gene expression. EBN on the other hand attenuated the HFD-
induced inflammation and oxidative stress and produced overall better outcomes in comparison with simvastatin.
Conclusions: In aggregate, the results support the evidence-based utilization of EBN as a supplement for preventing
obesity-related inflammation and oxidative stress in rats. These promising results can open up opportunities for
translating the benefits of EBN to humans.
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Background
The contribution of inflammation to many disease pro-
cesses is well established. In fact, many chronic diseases
have been associated with low grade inflammation [1].
Cardiometabolic diseases have been growing steadily
over the years and their burden is expected to rise sig-
nificantly in the near future if no urgent action is taken.
Despite advances in medical healthcare, the currently
available strategies for the management of cardiometa-
bolic diseases have not been completely effective in con-
trolling the burden of the diseases. Moreover, side
effects are limiting the use of some of these therapies,
and hence, the search for newer alternatives. Addition-
ally, links between diet and chronic disease development
are now strongly acknowledged, and this new under-
standing has widened the search for alternative therapies
to closely consider dietary methods of managing cardio-
metabolic diseases [2].
Edible bird’s nest (EBN) is a traditional supplement
consumed for its perceived health-promoting properties,
* Correspondence: mustyimam@gmail.com; maznahis@upm.edu.my
1Laboratory of Molecular Biomedicine, Institute of Bioscience, Universiti Putra
Malaysia, 43400 Serdang, Selangor, Malaysia
Full list of author information is available at the end of the article
© 2015 Yida et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Yida et al. BMC Complementary and Alternative Medicine  (2015) 15:310 
DOI 10.1186/s12906-015-0843-9
especially among Asians. However, there is lack of scien-
tific research to support the evidence-based use of EBN
as a supplement. Recent reports indicate that it pos-
sesses antioxidative and anti-inflammatory effects [3–5]
but the precise mechanisms underlying such effects are
not completely understood. Moreover, these reports are
from in vitro systems, which sometimes do not reflect
what happens in in vivo systems. Furthermore, the bio-
activity of foods with multiple constituents is often at-
tributed to their synergistic effects [6]. This is true of
EBN, which has many different constituents including
proteins, carbohydrates, fatty acids and other minerals
[7]. Additionally, we have recently reported that sialic
acid is a major protein constituent of EBN (11 % of
EBN), and may in fact be contributing significantly to its
bioactivity [8]. However, the contribution of its multiple
bioactives towards any of its effects cannot be ruled out
in view of the importance of food synergy in foods with
multiple constituents like EBN [6]. Thus, in view of the
lack of information on the effects of EBN on in vivo oxi-
dative stress and inflammation and the underlying
mechanisms involved, we tested the hypothesis that EBN
regulated hepatic antioxidant and anti-inflammatory




C-reactive protein (CRP), interleukin 6 (IL6) and tumor
necrosis factor alpha (Tnf-α) ELISA kits were purchased
from Elabscience Biotechnology Co., Ltd (Wuhan, China),
while 1,1,3,3-tetramethoxypropane (TMP), thiobarbituric
acid, potassium persulphate (K2S2O8), 2,2’-azino-bis [3-
ethylbenzothiazoline-6-sulphonic acid] (ABTS) reagent,
trolox standard and trichloroacetic acid were purchased
from Sigma Aldrich (St. Loius, MO, USA). RNA extrac-
tion kit was from RBC Bioscience Corp. (Taipei,
Taiwan) and GenomeLab™ GeXP Start Kit was from
Beckman Coulter Inc (Miami, FL, USA). Simvastatin,
RCL2 solution and lipid profile kits were from Pfizer
(New York, NY, USA), Alphelys (Toulouse, France) and
Randox Laboratories Ltd (Crumlin, County Antrim,
UK), respectively. Cholesterol and Cholic acid were
purchased from Amresco (Solon, OH, USA) and Santa
Cruz Biotechnology (Santa Cruz, CA, USA), respect-
ively. Standard rat pellet was from Specialty feeds (Glen
Forrest, WA, USA), while palm oil was supplied by Yee
Lee Edible oils Sdn. Bhd. (Perak, Malaysia). All other sol-
vents were of analytical grade and purchased from Merck
(Darmstadt, Germany). EBN supplied by Blossom View
Sdn. Bhd (Terrengganu, Malaysia) was cleaned under
tap water for 5 mins, dried at room temperature and
ground into powder manually using mortar and pestle
before incorporating it into rat pellet.
Animal study
Permission for the use of animals was sought from the
Animal Care and Use Committee (ACUC) of the Faculty
of Medicine and Health Sciences, Universiti Putra
Malaysia (Project approval number: UPM/IACUC/AUP-
R011/2014), and animals were handled as according to
standard guidelines. Sprague dawley rats (10-week old,
230–280 g, n = 30) were maintained under controlled
conditions (25 ± 2 °C, 12/12 h light/dark cycle) and after
2 weeks of acclimatization rats were fed HFD containing
4.5 % cholesterol and 0.5 % cholic acid with or without
treatment using Simvastatin or EBN (Table 1), except
the normal group (n = 6). Intervention lasted for another
12 weeks, after which rats were sacrificed and their or-
gans harvested for further studies. During the interven-
tion, food intake was calculated by subtracting the left-
over food from what was added the previous day, and
weight was recorded weekly. At the end of the interven-
tion, blood samples and liver tissues were collected for
further tests.
Liver Thiobarbituric acid reactive species (TBARS)
Liver tissue TBARS was measured as reported previ-
ously with some modifications [9]. Briefly, liver tissue
(80 mg) was homogenized in 250 uL of 0.25Hcl and
mixed with 250 uL of 0.375 % thiobarbituric acid and
250 uL of 15 % tricholoroacetic acid. Then, the mix-
ture was incubated at 100 °C for 10 min and cooled
before centrifuging at 3000 rpm for 15 min. Finally,
absorbance of 100 uL of each sample and standard
(TMP) were measured on BioTeK Synergy H1 Hybrid
Reader (BioTek Instruments Inc., Winooski, VT, USA) at
532 nm, and the results expressed as uM MDA/mg tissue.
Serum total Antioxidant status
ABTS radical scavenging activity was used as a marker
of total antioxidant status [10]. Briefly, 6.62 mg of potas-
sium persulphate, K2S2O8 was dissolved in 10 mL of dis-
tilled water to prepare a solution of 2.45 mM. Then,
7 mM ABTS was prepared by dissolving 38.4 mg in
10 mL distilled water. The two solutions were mixed
and incubated in the dark for 16 h prior to use, and di-
luted with distilled water until a spectrophotometric ab-
sorbance of 0.700 ± 0.005 at 735 nm was obtained.
Serum samples (100 μL) were reacted with 900 μL of the
diluted ABTS solution and vortexed. The absorbance
was read at 734 nm. ABTS radical cation scavenging ac-
tivity was calculated as the percentage reduction in
absorbance.
Serum C-reactive protein, Interleukin-6 and Tumor
necrosis factor-alpha
Serum from blood collected in plain tubes was used for
measurements of CRP, IL6 and Tnf-α using the
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respective ELISA kits according to the manufacturers’
instructions. Absorbances were read on BioTeK Synergy
H1 Hybrid Reader (BioTek Instruments Inc., Winooski,
VT, USA) at the 450 nm. The results were finally
expressed as fold change in comparison to normal
group:
Fold change = absorbance for the intervention group/
absorbance for the normal group
Gene expression study
Primers for the gene expression study (Table 2) were de-
signed using the Rattus norvegicus gene sequences from
the National Center for Biotechnology Information website
(http://www.ncbi.nlm.nih.gov/nucleotide/), and tagged with
an 18-nucleotide universal forward and 19-nucleotide uni-
versal reverse sequence, respectively. Primers were supplied
by Integrated DNA Technologies (Singapore) and
reconstituted in RNAse free water. Extracted hepatic RNA
(20 ng) was reverse transcribed and used for PCR according
to the GenomeLab™ GeXP Start Kit protocol (Beckman
Coulter, USA), using the conditions stated on Table 2. PCR
products (1 uL) were analyzed on GeXP genomelab genetic
analysis system (Beckman Coulter, Inc, Miami, FL, USA)
after mixing with sample loading solution and DNA size
standard 400 as recommended by the manufacturer. Re-
sults were analyzed with the Fragment Analysis module of
the GeXP system software and normalized on the eXpress
Profiler software.
Data analysis
The means ± standard deviation (n = 6) of the groups were
used for the analyses. One-way analysis of variance
(ANOVA) was performed using SPSS 17.0 software (SPSS
Table 1 Food composition of rat groups and intake













Normal 100 215.5 ± 33.5a 260.4 ± 10.7a 384 ± 22.9a
High fat diet 65 5 20 10 215.0 ± 37.5a 262.6 ± 17.7a 395.2 ± 16.8a
High fat diet + Simvastatin 65 5 20 10 Simvastatin
(10 mg/kg)
215.7 ± 36.6a 267.7 ± 21a 375.7 ± 53.4a
High fat diet + 20 % EBN 45 5 20 10 20 % EBN 216.1 ± 36.8a 261.7 ± 15.4a 380.7 ± 25.6a
High fat diet + 2.5 % EBN 62.5 5 20 10 2.5 % EBN 216.5 ± 35.8a 257 ± 20.1a 368 ± 29.3a
EBN: edible bird’s nest
Similar superscript letters (a) in each column indicate no statistically significant difference (p<0.05)
Table 2 Names, accession number and primer sequences used in the study















aHousekeeping genes. bNormalization gene. Underlined sequences are left and right universal left and right sequences (tags). cinternal control supplied by
Beckman Coulter Inc (Miami, FL, USA) as part of the GeXP kit. RT conditions were: 48 °C for 1 min; 37 °C for 5 min; 42 °C for 60 min; 95 °C for 5 min, then hold at
4 °C. PCR conditions were initial denaturation at 95 °C for 10 min, followed by two-step cycles of 94 °C for 30 s and 55 °C for 30 s, ending in a single extension
cycle of 68 °C for 1 min. B2m: Beta-2-Microglobulin; Ccl2: Chemokine (C-C Motif) Ligand 2; CRP: C-reactive protein; Gpx1: glutathione peroxidase 1; Gsr: glutathione
reductase; Hprt1: Hypoxanthine Phosphoribosyltransferase 1; IL6: interleukin 6; IL10: interleukin 10; KanR: Kanamycin resistant; nfkb1: nuclear factor Kappa B 1;
Rpl13a: Ribosomal Protein L13a; Sod:superoxide dismutase; Tnf: tumor necrosis factor
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Inc., Chicago, IL, USA) to assess the level of significance
of differences between means with a cutoff of p < 0.05.
Results and discussions
EBN attenuated high fat diet-induced oxidative stress
High fat diet-induced weight gain is often accompanied
by oxidative stress [11, 12]. In this study, high fat diet in-
creased weight gain and induced oxidative stress, which
were attenuated by EBN feeding (Table 1 & Fig. 1). The
results indicate that while high fat diet promoted oxida-
tive stress relative to normal group, EBN significantly at-
tenuated such a response, although no significant
differences were observed between the EBN groups.
Moreover, increased weight has been associated with
low grade inflammation and other cardiometabolic
health problems [13]. The level of TBARS in the Simva-
statin group was also lower than in the untreated control
group, but not significantly so. Furthermore, antioxidant
status in the different groups indicated that high fat diet
reduced antioxidants in comparison with the normal
group, while EBN prevented such an effect. Simvastatin
was similarly able to prevent reduction in antioxidant
status. The ability of EBN to reduce oxidative stress has
been ascribed to its antioxidant content, as demonstrated
in our recent publication where EBN was shown to pos-
sess potent antioxidant abilities that contributed towards
lowering of oxidative sterss markers [4]. This is similar to
what has been reported on the ability of antixidants to
scavenge free radicals thereby lowering oxidative stress
[14]. Conversely, the weight and oxidative stress modula-
tory effects of Simvastatin in rats have been reported pre-
viously [15].
EBN attenuated high fat diet induced inflammation
In the present study, EBN also attenuated EBN-induced
inflammatory response after 12 weeks of intervention
(Fig. 2). C-reactive protein (CRP), interleukin (IL) 6 and
tumor necrosis factor alpha (Tnf-α) were lower in the
EBN and Simvastatin groups. These results are in agree-
ment with previous findings on the anti-inflammatory
effects of EBN and Simvastatin [16]. Elevated CRP and
IL6 have been reported as important markers of the in-
flammatory response [17], while Tnf-α is involved in the
mediation of a number of processes including the in-
flammatory process [18]. Moreover, decreases in serum
levels of these markers (CRP, IL6 and Tnf-α) has been
associated with reduced inflammation [17, 18], and
Fig. 1 Effect of edible bird’s nest (EBN) on a) serum antioxidant status (expressed as % scavenging activity in relation to blank) and b) liver
thiobarbutric acid reactive species (expressed as malondialdehyde [MDA] equivalent) after 12 weeks intervention. The normal group received
standard rat chow, while the other groups received HFD containing 4.5 % cholesterol and 0.5 % cholic acid (untreated control group), HFD
containing 4.5 % cholesterol and 0.5 % cholic acid + 20 mg/kg/day Simvastatin (SIM), HFD containing 4.5 % cholesterol and 0.5 % cholic acid + 2.5 %
EBN (EBNL, EBN low) or HFD containing 4.5 % cholesterol and 0.5 % cholic acid + 20 % EBN (EBNH, EBN high). * indicates significant difference in
comparison with the normal group (p < 0.05). # indicates significant difference in comparison with the untreated control group (p < 0.05)
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therefore, the present results suggest that EBN has anti-
inflammatory effects in in vivo systems. It will be
recalled that the anti-inflammatory effects of EBN have
thus far been reported using in vitro system [3], and our
report provides more insight into such effects.
EBN regulated hepatic antioxidant and inflammatory
genes
Based on the antioxidant and anti-inflammatory effects
shown by EBN, we evaluated its effects on hepatic anti-
oxidant and inflammation-related genes (Table 1). High
fat diet feeding suppressed the expression of hepatic
antioxidant genes (Fig. 3; superoxide dismutase [SOD] 1
and 2, glutathione reductase [Gsr], and glutathione per-
oxidase [Gpx]), while EBN increased their expression.
The results suggest that increased expression of antioxi-
dants through transcriptional regulation may partly
underlie the increased antioxidant status in the rats that
consumed EBN. Moreover, increased expression of hep-
atic antioxidant genes has been associated with im-
proved antioxidant status [19]. Also, EBN showed a
dose-dependent effect on the expression of antioxidant
genes but not serum total antioxidant status possibly be-
cause post-transcriptional modifications produced effects
to the same degree irrespective of the degree of tran-
scriptional changes induced. The results suggest that
EBN will ultimately produce an all-or-none effect not-
withstanding the transcriptional changes.
Furthermore, high fat diet feeding increased expres-
sion of inflammatory genes (Fig. 4; CRP Tnf-α, chemo-
kine [C-C motif] ligand 2 [CCL2], and nuclear factor
Kappa B [nfkb]1), while EBN prevented these high fat
diet-induced changes. Increased expression of hepatic
inflammatory markers and suppression of the anti-
inflammatory marker suggested that high fat diet favoured
Fig. 2 Effect of edible bird’s nest (EBN) on serum markers of inflammation after 12 weeks intervention. Groupings are the same as Fig. 1. # indicates
significant difference in comparison with the untreated control group (p < 0.05). CRP: C-reactive protein; IL6: interleukin 6; TNF-α: tumor necrosis
factor alpha
Fig. 3 Effect of edible bird’s nest (EBN) on hepatic mRNA levels of
antioxidant genes after 12 weeks intervention. Groupings are the
same as Fig. 1. * indicates significant difference in comparison with
the normal group (p < 0.05). # indicates significant difference in
comparison with the untreated control group (p< 0.05). SOD: superoxide
dismutase; Gsr: glutathione reductase; Gpx: Glutathione peroxidase
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an increased inflammatory response, in keeping with earlier
findings [13]. EBN, on the other hand, prevented the in-
crease in expression of hepatic inflammatory markers,
which may underlie the reduced serum inflammatory
markers observed in this study; CRP and Tnf-α were re-
duced in the serum of the EBN groups. However, just as we
observed for the hepatic antioxidant genes, the dose-
dependent transcriptional changes induced by EBN were
not reflected by the results of the serum biomarkers. As
can be recalled, these observations may be due to post-
transcriptional modifications that produce an all-or-none
effect. Interestingly, despite lack of effect of EBN on the ex-
pression of the IL6 gene (data not shown), we observed a
change in its serum levels. The reduced serum IL6 despite
lack of any transcriptional effect of EBN on the IL6 gene
EBN further supports our hypothesis that EBN may have
multiple targets, and that the transcriptional changes ob-
served in this study may only partly explain the antioxidant
and anti-inflammatory effects of EBN. It is clear that other
mechanisms are involved in these effects, and are worth
studying further.
In aggregate, the ability of EBN to prevent high fat diet-
induced weight gain, oxidative stress and inflammation
suggests that it may be used as supplement to prevent
obesity-associated inflammation and consequent car-
diometabolic problems. Already, there are indications
that inflammation due to obesity may underlie the car-
diovascular and other metabolic diseases that are se-
quelae of excessive weight gain [13], and hence EBN
may be a good supplement for these problems since it
can prevent inflammation, oxidative stress and weight
gain. Recently, we demonstrated that the EBN used in
this study is predominantly made up of proteins and its
effects were likely mediated through synergistic effects
of its protein bioactives including sialic acid, lactoferrin
and ovotransferrin [8]. Other bioactives may be con-
tributing to this synergistic effect, and these findings
are worth evaluating further. The presence of contami-
nants has also been reported in EBN, which may coun-
ter any beneficial effects of EBN. Therefore, future
endeavours at studying the health effects of EBN and
especially its commercialization must employ stringent
screening methods to ensure no toxicity from con-
sumption of EBN.
Conclusions
The data demonstrated that EBN attenuated high fat
diet-induced oxidative stress and inflammation partly
through transcriptional regulation of hepatic antioxidant
and inflammation-related genes, better than Simvastatin.
The results also indicated that other post-transcriptional
mechanisms may be involved in antioxidant and anti-
inflammatory effects of EBN in rats. It is hoped that
these findings will open up opportunities for translating
the benefits of EBN to humans, and are worth evaluating
further.
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